OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Withdrawal of Immunomodulators or TNF Antagonists in Patients With Inflammatory Bowel Diseases in Remission on Combination Therapy: A Systematic Review and Meta-analysis
David J. Katibian, Virginia Solitano, D. Brent Polk, et al.
Clinical Gastroenterology and Hepatology (2023) Vol. 22, Iss. 1, pp. 22-33.e6
Closed Access | Times Cited: 7
David J. Katibian, Virginia Solitano, D. Brent Polk, et al.
Clinical Gastroenterology and Hepatology (2023) Vol. 22, Iss. 1, pp. 22-33.e6
Closed Access | Times Cited: 7
Showing 7 citing articles:
AGA Living Clinical Practice Guideline on Pharmacological Management of Moderate-to-Severe Ulcerative Colitis
Siddharth Singh, Edward V. Loftus, Berkeley N. Limketkai, et al.
Gastroenterology (2024) Vol. 167, Iss. 7, pp. 1307-1343
Closed Access | Times Cited: 7
Siddharth Singh, Edward V. Loftus, Berkeley N. Limketkai, et al.
Gastroenterology (2024) Vol. 167, Iss. 7, pp. 1307-1343
Closed Access | Times Cited: 7
Unmet needs of drugs for irritable bowel syndrome and inflammatory bowel diseases: interest of vagus nerve stimulation and hypnosis
Bruno Bonaz
Inflammopharmacology (2024) Vol. 32, Iss. 2, pp. 1005-1015
Closed Access | Times Cited: 3
Bruno Bonaz
Inflammopharmacology (2024) Vol. 32, Iss. 2, pp. 1005-1015
Closed Access | Times Cited: 3
Clinical impacts of immunomodulator withdrawal from anti‐tumor necrosis factor combination therapy in pediatric inflammatory bowel disease
Nicholas A. Iovino, Madeline G. McClinchie, Mahmoud Abdel‐Rasoul, et al.
Journal of Pediatric Gastroenterology and Nutrition (2024) Vol. 79, Iss. 4, pp. 885-894
Open Access
Nicholas A. Iovino, Madeline G. McClinchie, Mahmoud Abdel‐Rasoul, et al.
Journal of Pediatric Gastroenterology and Nutrition (2024) Vol. 79, Iss. 4, pp. 885-894
Open Access
Focusing on non-responders to infliximab with ulcerative colitis, what can we do first and next?
Dan Pu, Pengfei Wang, Xiang Wang, et al.
International Immunopharmacology (2024) Vol. 141, pp. 112943-112943
Closed Access
Dan Pu, Pengfei Wang, Xiang Wang, et al.
International Immunopharmacology (2024) Vol. 141, pp. 112943-112943
Closed Access
Interrupting inflammatory bowel disease therapy: why, who, when and how to consider medication holidays
Joëlle St‐Pierre, Asher Shafrir, David T. Rubin
Expert Review of Gastroenterology & Hepatology (2024) Vol. 18, Iss. 10, pp. 587-596
Closed Access
Joëlle St‐Pierre, Asher Shafrir, David T. Rubin
Expert Review of Gastroenterology & Hepatology (2024) Vol. 18, Iss. 10, pp. 587-596
Closed Access
Focusing on Non-Responders to Infliximab with Ulcerative Colitis, What Can We Do First and Next?
Dan Pu, Pengfei Wang, Xiang Wang, et al.
(2024)
Closed Access
Dan Pu, Pengfei Wang, Xiang Wang, et al.
(2024)
Closed Access
Challenging Conventional Care: Ethical Considerations of De-intensification of Therapy in IBD
Joëlle St‐Pierre, David T. Rubin
Gastroenterology (2024)
Closed Access
Joëlle St‐Pierre, David T. Rubin
Gastroenterology (2024)
Closed Access
